282 related articles for article (PubMed ID: 27836762)
1. Passive immunization against Pseudomonas aeruginosa recombinant PilA in a murine burn wound model.
Mousavi M; Behrouz B; Irajian G; Mahdavi M; Korpi F; Motamedifar M
Microb Pathog; 2016 Dec; 101():83-88. PubMed ID: 27836762
[TBL] [Abstract][Full Text] [Related]
2. Flagellin and pilin immunization against multi-drug resistant Pseudomonas aeruginosa protects mice in the burn wound sepsis model.
Korpi F; Hashemi FB; Irajian G; Fatemi MJ; Laghaei P; Behrouz B
Immunol Lett; 2016 Aug; 176():8-17. PubMed ID: 27210422
[TBL] [Abstract][Full Text] [Related]
3. Passive immunisation against Pseudomonas aeruginosa recombinant flagellin in an experimental model of burn wound sepsis.
Faezi S; Sattari M; Mahdavi M; Roudkenar MH
Burns; 2011 Aug; 37(5):865-72. PubMed ID: 21334822
[TBL] [Abstract][Full Text] [Related]
4. Antibodies raised against divalent type b flagellin and pilin provide effective immunotherapy against Pseudomonas aeruginosa infection of mice with burn wounds.
Saffari M; Behbood S; Irajian G; Khorshidi A; Moniri R; Behrouz B
Biologicals; 2017 Jan; 45():20-26. PubMed ID: 27836582
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of the immune responses following co-administration of PilQ and type b-flagellin from Pseudomonas aeruginosa in the burn mouse model.
Bakht Azad S; Nikokar I; Faezi S; Rasooly S; Mahdavi M
Microb Pathog; 2018 Oct; 123():426-432. PubMed ID: 30075242
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of antibodies against the N-terminal of Pseudomonas aeruginosa flagellin for treating infections in a murine burn wound model.
Barnea Y; Carmeli Y; Gur E; Kuzmenko B; Gat A; Neville LF; Eren R; Dagan S; Navon-Venezia S
Plast Reconstr Surg; 2006 Jun; 117(7):2284-91. PubMed ID: 16772930
[TBL] [Abstract][Full Text] [Related]
7. Passive immunization with anti- chimeric protein PilQ/PilA -DSL region IgY does not protect against mortality associated with Pseudomonas aeruginosa sepsis in a rabbit model.
Zamani K; Irajian G; Zahedi Bialvaei A; Zahraei Salehi T; Khormali M; Vosough A; Masjedian Jazi F
Mol Immunol; 2022 Jan; 141():258-264. PubMed ID: 34896925
[TBL] [Abstract][Full Text] [Related]
8. Protective efficacy of Pseudomonas aeruginosa type-A flagellin in the murine burn wound model of infection.
Faezi S; Safarloo M; Amirmozafari N; Nikokar I; Siadat SD; Holder IA; Mahdavi M
APMIS; 2014 Feb; 122(2):115-27. PubMed ID: 23758581
[TBL] [Abstract][Full Text] [Related]
9. A trivalent vaccine consisting of "flagellin A+B and pilin" protects against Pseudomonas aeruginosa infection in a murine burn model.
Hashemi FB; Behrouz B; Irajian G; Laghaei P; Korpi F; Fatemi MJ
Microb Pathog; 2020 Jan; 138():103697. PubMed ID: 31465785
[TBL] [Abstract][Full Text] [Related]
10. Protective effect of pilin protein with alum+naloxone adjuvant against acute pulmonary Pseudomonas aeruginosa infection.
Banadkoki AZ; Keshavarzmehr M; Afshar Z; Aleyasin N; Fatemi MJ; Behrouz B; Hashemi FB
Biologicals; 2016 Sep; 44(5):367-73. PubMed ID: 27427517
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of locally delivered polyclonal immunoglobulin against Pseudomonas aeruginosa infection in a murine burn wound model.
Felts AG; Giridhar G; Grainger DW; Slunt JB
Burns; 1999 Aug; 25(5):415-23. PubMed ID: 10439150
[TBL] [Abstract][Full Text] [Related]
12. Active Immunization with Recombinant PilA protein Protects Against Pseudomonas aeruginosa Infection in a Mouse Burn Wound Model.
Korpi F; Irajian G; Mahadavi M; Motamedifar M; Mousavi M; Laghaei P; Raei N; Behrouz B
J Microbiol Biotechnol; 2015 Sep; ():. PubMed ID: 26387817
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of a fusion protein containing PilQ and disulphide turn region of PilA from Pseudomonas aeruginosa in mice.
Gholami M; Chirani AS; Razavi S; Falak R; Irajian G
Lett Appl Microbiol; 2017 Nov; 65(5):439-445. PubMed ID: 28857243
[TBL] [Abstract][Full Text] [Related]
14. Immunotherapy with IgY Antibodies toward Outer Membrane Protein F Protects Burned Mice against
Norouzi F; Behrouz B; Ranjbar M; Mousavi Gargari SL
J Immunol Res; 2020; 2020():7840631. PubMed ID: 32566689
[TBL] [Abstract][Full Text] [Related]
15. The prophylactic effects of human IgG derived from sera containing high anti-PcrV titers against pneumonia-causing Pseudomonas aeruginosa.
Kinoshita M; Kato H; Yasumoto H; Shimizu M; Hamaoka S; Naito Y; Akiyama K; Moriyama K; Sawa T
Hum Vaccin Immunother; 2016 Nov; 12(11):2833-2846. PubMed ID: 27454613
[TBL] [Abstract][Full Text] [Related]
16. Immunization with 3-oxododecanoyl-L-homoserine lactone-r-PcrV conjugate enhances survival of mice against lethal burn infections caused by Pseudomonas aeruginosa.
Golpasha ID; Mousavi SF; Owlia P; Siadat SD; Irani S
Bosn J Basic Med Sci; 2015 May; 15(2):15-24. PubMed ID: 26042508
[TBL] [Abstract][Full Text] [Related]
17. Immunization of burn-patients with a Pseudomonas aeruginosa outer membrane protein vaccine elicits antibodies with protective efficacy.
Lee NG; Jung SB; Ahn BY; Kim YH; Kim JJ; Kim DK; Kim IS; Yoon SM; Nam SW; Kim HS; Park WJ
Vaccine; 2000 Mar; 18(18):1952-61. PubMed ID: 10699346
[TBL] [Abstract][Full Text] [Related]
18. Bivalent flagellin immunotherapy protects mice against Pseudomonas aeruginosa infections in both acute pneumonia and burn wound models.
Ahmadi H; Behrouz B; Irajian G; Amirmozafari N; Naghavi S
Biologicals; 2017 Mar; 46():29-37. PubMed ID: 28065582
[TBL] [Abstract][Full Text] [Related]
19. Intratracheal immunization with pili protein protects against mortality associated with Pseudomonas aeruginosa pneumonia in mice.
Ohama M; Hiramatsu K; Miyajima Y; Kishi K; Nasu M; Kadota J
FEMS Immunol Med Microbiol; 2006 Jun; 47(1):107-15. PubMed ID: 16706793
[TBL] [Abstract][Full Text] [Related]
20. In-Silico Analysis and Protective Efficacy of the PcrV Recombinant Vaccine against Pseudomonas Aeruginosa in the Burned and PA-Infected BALB/c Mouse Model.
Fakoor MH; Owlia P; Mousavi Gargari SL; Sabokbar A
Iran J Immunol; 2020 Jun; 17(2):121-136. PubMed ID: 32602466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
